PHILADELPHIA and LONDON, June 30 /PRNewswire/ -- THE PLANNING SHOP international (TPSi) is pleased to announce the launch of its new Oncology Business Unit (OBU) which will be fully dedicated to the oncology therapeutic area. This announcement was made at the European Pharmaceutical Market Research Association (EphMRA) Conference, which was held June 22-24, 2010, in Berlin, Germany.
Oncology is a complex, fast moving therapeutic area. Numerous pharmaceutical products are currently approved or under development for the treatment of more than 200 different types of cancer. Conducting oncology market research is challenging because it is difficult to find a marketing research agency that truly understands the therapeutic area as well as the brand implications of various investigational and marketed pharmaceutical products. The TPSi OBU consists of a team that is fully dedicated to oncology projects and is led by market research professionals who are experts in both the therapeutic area and the relevant associated brands. Leading the OBU is Kelly Price, who has spent eight years working in both syndicated and customized oncology research in Japan, China, throughout Asia Pacific, and most recently in the United States.
"TPSi is delighted to welcome Kelly Price to head up its new Oncology Business Unit," said Kim Hughes, Managing Director, TPSi London. "Her joining TPSi represents the merger of deep oncology therapy knowledge with broad brand understanding, the synergies of which will provide clients with brand strategy for a fast-shifting clinical context."
The TPSi Oncology Business Unit was established when the company recognized that most of its clients were increasingly involved in oncology -- either marketing existing compounds or developing new compounds. According to Sherry Fox, President, TPSi North America and founder of the unit, "We recognized the need for a dedicated division focused on oncology, so we set out to find a leader who would contribute the necessary expertise. Many of our clients are specifically asking for this level of oncology knowledge, which combined with our brand strategy experience will provide a complete solution to oncology marketing research needs."
About THE PLANNING SHOP international
THE PLANNING SHOP international was established in 1987 as a strategic brand consultancy. The company quickly expanded into market research and the pharmaceutical industry in particular, on which it now focuses 100% of its efforts. The organization's unique brand-building market research products, delivered through branding and consultancy experience, makes TPSi unique in the pharmaceutical market research sector. Constantly innovating by using new techniques, TPSi is committed to helping its clients build superior brands from Phase 2 to in-market. With offices in London, Brussels, and Philadelphia, TPSi focuses on brand strategy in addition to market research, working on behalf of clients around the globe.
SOURCE THE PLANNING SHOP international